Esperion announced Wednesday it has completed its acquisition of Corstasis Therapeutics Inc., gaining the first FDA-approved ...

AtaiBeckley (NasdaqGM:ATAI) reported positive, peer reviewed Phase 2a results for its lead psychedelic drug BPL-003 in ...

Children were previously required to weigh ≥33 lbs. and <66 lbs. and be at least four years of age to receive neffy 1 mg dose - approval enables families of younger ...

ARS Pharmaceuticals received approval from the Food and Drug Administration to remove the age requirement for its neffy nasal spray to treat allergic reactions. Children were previously required to be ...

ABC News’ Ike Ejiochi follows two patients taking an FDA-approved esketamine nasal spray for their treatment-resistant depression to better understand the drug’s effects. White House calls new ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an update to the neffy 1 mg prescribing information so that age is not a factor in when to use ...

Add Yahoo as a preferred source to see more of our stories on Google. ABC News’ Ike Ejiochi follows two patients taking an FDA-approved esketamine nasal spray for their treatment-resistant depression ...

The FDA has approved Denali Therapeutics’ enzyme replacement therapy for a genetic lysosomal storage disease after a string of high-profile rejections for rare disease candidates. In approving ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist, for the treatment of moderate-to-severe plaque psoriasis in ...

The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection. The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and ...

The US Food and Drug Administration has approved the Trilogy transcatheter heart valve (JenaValve) for patients with symptomatic severe aortic regurgitation at high risk for surgery, according to an ...